AI-assisted breast cancer screening showed minor clinical benefits over DBT alone but was not cost-effective at standard willingness-to-pay thresholds.
Key Details
- 1Study published in Value in Health evaluated the cost-effectiveness of AI (Saige-DX) in breast cancer screening.
- 2Microsimulation compared digital breast tomosynthesis (DBT) alone and DBT plus AI for women aged 40–74 in biennial screening.
- 3AI reduced false negatives by 2.1 and false positives by 50 per 1,000 women; 0.13 fewer breast cancer deaths per 1,000.
- 4AI-assisted screening led to 3.09 additional QALYs but added $936,430 in lifetime costs per 1,000 women (ICER: $303,279/QALY).
- 5AI was not cost-effective at a $100,000/QALY threshold in 98% of simulations, mainly due to 21% increase in DCIS diagnoses.
- 6Cost-effectiveness did not improve even at very low AI pricing in most scenarios.
Why It Matters
Although AI can modestly improve accuracy in breast cancer screening, this study highlights persistent cost-effectiveness concerns, especially with increased DCIS detection. This underscores an economic and clinical challenge for broader AI adoption in screening workflows.
Source
AuntMinnie
Related News
•AuntMinnie
AI-Enhanced Chest X-rays Improve COPD Mortality Prediction
An open-source AI model using chest x-rays accurately predicts respiratory mortality in COPD patients, outperforming standard clinical risk grading.
•Radiology Business
Rayus Radiology Launches $40 AI Mammography Screenings in Washington
Rayus Radiology is introducing a $40 AI-enhanced mammography add-on service at clinics in Washington state.
•AuntMinnie
AI-CAD Demonstrates High Sensitivity in Breast Cancer Screening
A large study found that AI-based computer-aided detection (AI-CAD) can improve breast cancer detection and support radiologists in screening mammography.